0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Solid Preparation Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-4K13976
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Solid Preparation Drug Market Research Report 2023
BUY CHAPTERS

Solid Preparation Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4K13976
Report
September 2024
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Solid Preparation Drug - Market Size

The global market for Solid Preparation Drug was estimated to be worth US$ 551240 million in 2023 and is forecast to a readjusted size of US$ 847810 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030

Solid Preparation Drug - Market

Solid Preparation Drug - Market

Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Solid Preparation Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Solid Preparation Drug by region & country, by Type, and by Application.
The Solid Preparation Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Preparation Drug.
Market Segmentation

Scope of Solid Preparation Drug - Market Report

Report Metric Details
Report Name Solid Preparation Drug - Market
Forecasted market size in 2030 US$ 847810 million
CAGR 6.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Tablet
  • Capsules
  • Other
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Teva, Boehringer Ingelheim, Biogen, Astellas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Solid Preparation Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Solid Preparation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Solid Preparation Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Solid Preparation Drug - Market size in 2030?

Ans: The Solid Preparation Drug - Market size in 2030 will be US$ 847810 million.

Who are the main players in the Solid Preparation Drug - Market report?

Ans: The main players in the Solid Preparation Drug - Market are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Teva, Boehringer Ingelheim, Biogen, Astellas

What are the Application segmentation covered in the Solid Preparation Drug - Market report?

Ans: The Applications covered in the Solid Preparation Drug - Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Solid Preparation Drug - Market report?

Ans: The Types covered in the Solid Preparation Drug - Market report are Tablet, Capsules, Other

1 Market Overview
1.1 Solid Preparation Drug Product Introduction
1.2 Global Solid Preparation Drug Market Size Forecast
1.3 Solid Preparation Drug Market Trends & Drivers
1.3.1 Solid Preparation Drug Industry Trends
1.3.2 Solid Preparation Drug Market Drivers & Opportunity
1.3.3 Solid Preparation Drug Market Challenges
1.3.4 Solid Preparation Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Solid Preparation Drug Players Revenue Ranking (2023)
2.2 Global Solid Preparation Drug Revenue by Company (2019-2024)
2.3 Key Companies Solid Preparation Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Solid Preparation Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Solid Preparation Drug
2.6 Solid Preparation Drug Market Competitive Analysis
2.6.1 Solid Preparation Drug Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Solid Preparation Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Preparation Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Capsules
3.1.3 Other
3.2 Global Solid Preparation Drug Sales Value by Type
3.2.1 Global Solid Preparation Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Solid Preparation Drug Sales Value, by Type (2019-2030)
3.2.3 Global Solid Preparation Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Other
4.2 Global Solid Preparation Drug Sales Value by Application
4.2.1 Global Solid Preparation Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Solid Preparation Drug Sales Value, by Application (2019-2030)
4.2.3 Global Solid Preparation Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Solid Preparation Drug Sales Value by Region
5.1.1 Global Solid Preparation Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Solid Preparation Drug Sales Value by Region (2019-2024)
5.1.3 Global Solid Preparation Drug Sales Value by Region (2025-2030)
5.1.4 Global Solid Preparation Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Solid Preparation Drug Sales Value, 2019-2030
5.2.2 North America Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Solid Preparation Drug Sales Value, 2019-2030
5.3.2 Europe Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Solid Preparation Drug Sales Value, 2019-2030
5.4.2 Asia Pacific Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Solid Preparation Drug Sales Value, 2019-2030
5.5.2 South America Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Solid Preparation Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Solid Preparation Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Solid Preparation Drug Sales Value
6.3 United States
6.3.1 United States Solid Preparation Drug Sales Value, 2019-2030
6.3.2 United States Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Solid Preparation Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Solid Preparation Drug Sales Value, 2019-2030
6.4.2 Europe Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Solid Preparation Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Solid Preparation Drug Sales Value, 2019-2030
6.5.2 China Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Solid Preparation Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Solid Preparation Drug Sales Value, 2019-2030
6.6.2 Japan Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Solid Preparation Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Solid Preparation Drug Sales Value, 2019-2030
6.7.2 South Korea Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Solid Preparation Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Solid Preparation Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Solid Preparation Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Solid Preparation Drug Sales Value, 2019-2030
6.9.2 India Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Solid Preparation Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Profile
7.1.2 Johnson & Johnson Main Business
7.1.3 Johnson & Johnson Solid Preparation Drug Products, Services and Solutions
7.1.4 Johnson & Johnson Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Johnson & Johnson Recent Developments
7.2 Novartis
7.2.1 Novartis Profile
7.2.2 Novartis Main Business
7.2.3 Novartis Solid Preparation Drug Products, Services and Solutions
7.2.4 Novartis Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.2.5 Novartis Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Solid Preparation Drug Products, Services and Solutions
7.3.4 Roche Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.3.5 AbbVie Recent Developments
7.4 AbbVie
7.4.1 AbbVie Profile
7.4.2 AbbVie Main Business
7.4.3 AbbVie Solid Preparation Drug Products, Services and Solutions
7.4.4 AbbVie Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.4.5 AbbVie Recent Developments
7.5 Merck & Co.
7.5.1 Merck & Co. Profile
7.5.2 Merck & Co. Main Business
7.5.3 Merck & Co. Solid Preparation Drug Products, Services and Solutions
7.5.4 Merck & Co. Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Merck & Co. Recent Developments
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Profile
7.6.2 Bristol Myers Squibb Main Business
7.6.3 Bristol Myers Squibb Solid Preparation Drug Products, Services and Solutions
7.6.4 Bristol Myers Squibb Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Bristol Myers Squibb Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Profile
7.7.2 GlaxoSmithKline Main Business
7.7.3 GlaxoSmithKline Solid Preparation Drug Products, Services and Solutions
7.7.4 GlaxoSmithKline Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.7.5 GlaxoSmithKline Recent Developments
7.8 Pfizer
7.8.1 Pfizer Profile
7.8.2 Pfizer Main Business
7.8.3 Pfizer Solid Preparation Drug Products, Services and Solutions
7.8.4 Pfizer Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Recent Developments
7.9 Sanofi
7.9.1 Sanofi Profile
7.9.2 Sanofi Main Business
7.9.3 Sanofi Solid Preparation Drug Products, Services and Solutions
7.9.4 Sanofi Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Sanofi Recent Developments
7.10 Takeda
7.10.1 Takeda Profile
7.10.2 Takeda Main Business
7.10.3 Takeda Solid Preparation Drug Products, Services and Solutions
7.10.4 Takeda Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Takeda Recent Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Profile
7.11.2 AstraZeneca Main Business
7.11.3 AstraZeneca Solid Preparation Drug Products, Services and Solutions
7.11.4 AstraZeneca Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.11.5 AstraZeneca Recent Developments
7.12 Bayer
7.12.1 Bayer Profile
7.12.2 Bayer Main Business
7.12.3 Bayer Solid Preparation Drug Products, Services and Solutions
7.12.4 Bayer Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.12.5 Bayer Recent Developments
7.13 Eli Lilly & Co.
7.13.1 Eli Lilly & Co. Profile
7.13.2 Eli Lilly & Co. Main Business
7.13.3 Eli Lilly & Co. Solid Preparation Drug Products, Services and Solutions
7.13.4 Eli Lilly & Co. Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.13.5 Eli Lilly & Co. Recent Developments
7.14 Gilead Sciences
7.14.1 Gilead Sciences Profile
7.14.2 Gilead Sciences Main Business
7.14.3 Gilead Sciences Solid Preparation Drug Products, Services and Solutions
7.14.4 Gilead Sciences Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.14.5 Gilead Sciences Recent Developments
7.15 Amgen
7.15.1 Amgen Profile
7.15.2 Amgen Main Business
7.15.3 Amgen Solid Preparation Drug Products, Services and Solutions
7.15.4 Amgen Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.15.5 Amgen Recent Developments
7.16 Teva
7.16.1 Teva Profile
7.16.2 Teva Main Business
7.16.3 Teva Solid Preparation Drug Products, Services and Solutions
7.16.4 Teva Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.16.5 Teva Recent Developments
7.17 Boehringer Ingelheim
7.17.1 Boehringer Ingelheim Profile
7.17.2 Boehringer Ingelheim Main Business
7.17.3 Boehringer Ingelheim Solid Preparation Drug Products, Services and Solutions
7.17.4 Boehringer Ingelheim Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.17.5 Boehringer Ingelheim Recent Developments
7.18 Biogen
7.18.1 Biogen Profile
7.18.2 Biogen Main Business
7.18.3 Biogen Solid Preparation Drug Products, Services and Solutions
7.18.4 Biogen Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.18.5 Biogen Recent Developments
7.19 Astellas
7.19.1 Astellas Profile
7.19.2 Astellas Main Business
7.19.3 Astellas Solid Preparation Drug Products, Services and Solutions
7.19.4 Astellas Solid Preparation Drug Revenue (US$ Million) & (2019-2024)
7.19.5 Astellas Recent Developments
8 Industry Chain Analysis
8.1 Solid Preparation Drug Industrial Chain
8.2 Solid Preparation Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Solid Preparation Drug Sales Model
8.5.2 Sales Channel
8.5.3 Solid Preparation Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Solid Preparation Drug Market Trends
    Table 2. Solid Preparation Drug Market Drivers & Opportunity
    Table 3. Solid Preparation Drug Market Challenges
    Table 4. Solid Preparation Drug Market Restraints
    Table 5. Global Solid Preparation Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Solid Preparation Drug Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Solid Preparation Drug Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Solid Preparation Drug Product Type
    Table 9. Key Companies Time to Begin Mass Production of Solid Preparation Drug
    Table 10. Global Solid Preparation Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Preparation Drug as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Solid Preparation Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Solid Preparation Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Solid Preparation Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Solid Preparation Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Solid Preparation Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Solid Preparation Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Solid Preparation Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Solid Preparation Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Solid Preparation Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Solid Preparation Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Solid Preparation Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Solid Preparation Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Solid Preparation Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Solid Preparation Drug Sales Value by Region (2019-2024) & (%)
    Table 27. Global Solid Preparation Drug Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Solid Preparation Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Solid Preparation Drug Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Solid Preparation Drug Sales Value, (2025-2030) & (US$ Million)
    Table 31. Johnson & Johnson Basic Information List
    Table 32. Johnson & Johnson Description and Business Overview
    Table 33. Johnson & Johnson Solid Preparation Drug Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Solid Preparation Drug Business of Johnson & Johnson (2019-2024)
    Table 35. Johnson & Johnson Recent Developments
    Table 36. Novartis Basic Information List
    Table 37. Novartis Description and Business Overview
    Table 38. Novartis Solid Preparation Drug Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Solid Preparation Drug Business of Novartis (2019-2024)
    Table 40. Novartis Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche Solid Preparation Drug Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Solid Preparation Drug Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. AbbVie Basic Information List
    Table 47. AbbVie Description and Business Overview
    Table 48. AbbVie Solid Preparation Drug Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Solid Preparation Drug Business of AbbVie (2019-2024)
    Table 50. AbbVie Recent Developments
    Table 51. Merck & Co. Basic Information List
    Table 52. Merck & Co. Description and Business Overview
    Table 53. Merck & Co. Solid Preparation Drug Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Solid Preparation Drug Business of Merck & Co. (2019-2024)
    Table 55. Merck & Co. Recent Developments
    Table 56. Bristol Myers Squibb Basic Information List
    Table 57. Bristol Myers Squibb Description and Business Overview
    Table 58. Bristol Myers Squibb Solid Preparation Drug Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Solid Preparation Drug Business of Bristol Myers Squibb (2019-2024)
    Table 60. Bristol Myers Squibb Recent Developments
    Table 61. GlaxoSmithKline Basic Information List
    Table 62. GlaxoSmithKline Description and Business Overview
    Table 63. GlaxoSmithKline Solid Preparation Drug Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Solid Preparation Drug Business of GlaxoSmithKline (2019-2024)
    Table 65. GlaxoSmithKline Recent Developments
    Table 66. Pfizer Basic Information List
    Table 67. Pfizer Description and Business Overview
    Table 68. Pfizer Solid Preparation Drug Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Solid Preparation Drug Business of Pfizer (2019-2024)
    Table 70. Pfizer Recent Developments
    Table 71. Sanofi Basic Information List
    Table 72. Sanofi Description and Business Overview
    Table 73. Sanofi Solid Preparation Drug Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Solid Preparation Drug Business of Sanofi (2019-2024)
    Table 75. Sanofi Recent Developments
    Table 76. Takeda Basic Information List
    Table 77. Takeda Description and Business Overview
    Table 78. Takeda Solid Preparation Drug Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Solid Preparation Drug Business of Takeda (2019-2024)
    Table 80. Takeda Recent Developments
    Table 81. AstraZeneca Basic Information List
    Table 82. AstraZeneca Description and Business Overview
    Table 83. AstraZeneca Solid Preparation Drug Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Solid Preparation Drug Business of AstraZeneca (2019-2024)
    Table 85. AstraZeneca Recent Developments
    Table 86. Bayer Basic Information List
    Table 87. Bayer Description and Business Overview
    Table 88. Bayer Solid Preparation Drug Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Solid Preparation Drug Business of Bayer (2019-2024)
    Table 90. Bayer Recent Developments
    Table 91. Eli Lilly & Co. Basic Information List
    Table 92. Eli Lilly & Co. Description and Business Overview
    Table 93. Eli Lilly & Co. Solid Preparation Drug Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Solid Preparation Drug Business of Eli Lilly & Co. (2019-2024)
    Table 95. Eli Lilly & Co. Recent Developments
    Table 96. Gilead Sciences Basic Information List
    Table 97. Gilead Sciences Description and Business Overview
    Table 98. Gilead Sciences Solid Preparation Drug Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Solid Preparation Drug Business of Gilead Sciences (2019-2024)
    Table 100. Gilead Sciences Recent Developments
    Table 101. Amgen Basic Information List
    Table 102. Amgen Description and Business Overview
    Table 103. Amgen Solid Preparation Drug Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Solid Preparation Drug Business of Amgen (2019-2024)
    Table 105. Amgen Recent Developments
    Table 106. Teva Basic Information List
    Table 107. Teva Description and Business Overview
    Table 108. Teva Solid Preparation Drug Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Solid Preparation Drug Business of Teva (2019-2024)
    Table 110. Teva Recent Developments
    Table 111. Boehringer Ingelheim Basic Information List
    Table 112. Boehringer Ingelheim Description and Business Overview
    Table 113. Boehringer Ingelheim Solid Preparation Drug Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Solid Preparation Drug Business of Boehringer Ingelheim (2019-2024)
    Table 115. Boehringer Ingelheim Recent Developments
    Table 116. Biogen Basic Information List
    Table 117. Biogen Description and Business Overview
    Table 118. Biogen Solid Preparation Drug Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Solid Preparation Drug Business of Biogen (2019-2024)
    Table 120. Biogen Recent Developments
    Table 121. Astellas Basic Information List
    Table 122. Astellas Description and Business Overview
    Table 123. Astellas Solid Preparation Drug Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Solid Preparation Drug Business of Astellas (2019-2024)
    Table 125. Astellas Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Solid Preparation Drug Downstream Customers
    Table 129. Solid Preparation Drug Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Solid Preparation Drug Product Picture
    Figure 2. Global Solid Preparation Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Solid Preparation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Solid Preparation Drug Report Years Considered
    Figure 5. Global Solid Preparation Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Solid Preparation Drug Revenue in 2023
    Figure 7. Solid Preparation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Tablet Picture
    Figure 9. Capsules Picture
    Figure 10. Other Picture
    Figure 11. Global Solid Preparation Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Solid Preparation Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospital
    Figure 14. Product Picture of Retail Pharmacy
    Figure 15. Product Picture of Other
    Figure 16. Global Solid Preparation Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Solid Preparation Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Solid Preparation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Solid Preparation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Solid Preparation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Solid Preparation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Solid Preparation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Solid Preparation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Solid Preparation Drug Sales Value (%), (2019-2030)
    Figure 29. United States Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Solid Preparation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Solid Preparation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Solid Preparation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 50. Solid Preparation Drug Industrial Chain
    Figure 51. Solid Preparation Drug Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Drugs to Treat Hypertriglyceridemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37P13132
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Add to Cart

Medications for Actinic Keratosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36R13742
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Melatonin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-21J13714
Wed Nov 06 00:00:00 UTC 2024

Add to Cart